Kunzheng Wang Selected Research

Osteosarcoma (Osteogenic Sarcoma)

11/2020	Long noncoding RNA PWRN1 is lowly expressed in osteosarcoma and modulates cancer proliferation and migration by targeting hsa-miR-214-5p.
1/2020	MicroRNA-211-5p promotes apoptosis and inhibits the migration of osteosarcoma cells by targeting proline-rich protein PRR11.
11/2019	The induction of ferroptosis by impairing STAT3/Nrf2/GPx4 signaling enhances the sensitivity of osteosarcoma cells to cisplatin.
1/2019	The role of chamaejasmine in cellular apoptosis and autophagy in MG-63 cells.
1/2018	MiR-30a-5p inhibits osteosarcoma cell proliferation and migration by targeting FOXD1.
1/2018	Downregulation of microRNA-15a-3p is correlated with clinical outcome and negatively regulates cancer proliferation and migration in human osteosarcoma.
1/2017	DNA Methylation Mediated Down-Regulation of miR-370 Regulates Cell Growth through Activation of the Wnt/β-Catenin Signaling Pathway in Human Osteosarcoma Cells.
1/2016	The Roles of Sox Family Genes in Sarcoma.
1/2016	Fibroblast growth factor receptor 1 promotes MG63 cell proliferation and is associated with increased expression of cyclin-dependent kinase 1 in osteosarcoma.
1/2015	miR-203 Acts as a Tumor Suppressor Gene in Osteosarcoma by Regulating RAB22A.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kunzheng Wang Research Topics

Disease

27	Osteonecrosis (Kienbock's Disease) 04/2022 - 03/2007
13	Necrosis 04/2022 - 02/2000
10	Osteosarcoma (Osteogenic Sarcoma) 11/2020 - 01/2015
10	Neoplasms (Cancer) 11/2020 - 02/2011
9	Inflammation (Inflammations) 04/2022 - 02/2011
7	Osteoporosis 02/2022 - 04/2006
6	Osteoarthritis 10/2021 - 12/2015
5	Femoral Neck Fractures 01/2022 - 04/2011
5	Pain (Aches) 01/2021 - 09/2010
5	Hypoxia (Hypoxemia) 08/2016 - 01/2014
5	Developmental Dysplasia of the Hip 01/2015 - 10/2007
4	Bone Resorption 03/2021 - 05/2013
4	Neoplasm Metastasis (Metastasis) 01/2020 - 09/2015
4	Reperfusion Injury 01/2012 - 06/2006
3	Fibrosis (Cirrhosis) 10/2021 - 10/2015
3	Infections 05/2021 - 12/2018
3	Spinal Cord Ischemia 01/2012 - 07/2010
2	Postmenopausal Osteoporosis 01/2022 - 10/2005
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 12/2021 - 12/2021
2	Wounds and Injuries (Trauma) 05/2021 - 09/2020
2	Knee Osteoarthritis 06/2019 - 01/2018
2	Arthritis (Polyarthritis) 10/2018 - 01/2017
2	Hip Fractures (Intertrochanteric Fractures) 08/2017 - 01/2012
2	Body Weight (Weight, Body) 01/2017 - 01/2014
2	Chondrosarcoma 01/2016 - 09/2015
2	Carcinogenesis 09/2015 - 01/2015
2	Edema (Dropsy) 06/2015 - 01/2012
2	AIDS-Related Complex (ARC) 02/2013 - 01/2012
2	Spinal Cord Injuries (Spinal Cord Injury) 02/2012 - 02/2011
2	Infarction (Infarctions) 07/2011 - 07/2010
1	Coinfection 05/2021
1	Arthralgia (Joint Pain) 01/2021
1	Hemarthrosis 01/2021
1	Synovitis 01/2021
1	Surgical Wound 09/2020
1	Reinfection 12/2018
1	Pressure Ulcer (Bedsore) 12/2018

Drug/Important Bio-Agent (IBA)

18	SteroidsIBA 03/2020 - 02/2000
7	Biomarkers (Surrogate Marker)IBA 01/2022 - 09/2015
7	Proteins (Proteins, Gene)FDA Link 01/2020 - 01/2006
6	GlucocorticoidsIBA 04/2022 - 12/2004
5	CateninsIBA 02/2022 - 11/2015
5	MicroRNAs (MicroRNA)IBA 12/2021 - 01/2015
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2016 - 04/2010
4	OsteoprotegerinIBA 04/2022 - 10/2005
4	Pharmaceutical PreparationsIBA 01/2022 - 01/2020
4	Messenger RNA (mRNA)IBA 01/2022 - 10/2005
4	Biological ProductsIBA 01/2018 - 04/2010
3	RNA (Ribonucleic Acid)IBA 01/2022 - 04/2018
3	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 04/2018 - 08/2012
3	Neuroprotective AgentsIBA 06/2015 - 07/2011
3	Oxygen (Dioxygen)IBA 01/2015 - 11/2011
3	Bone Morphogenetic Protein 7IBA 12/2010 - 04/2010
2	Therapeutic UsesIBA 04/2022 - 10/2006
2	Long Noncoding RNAIBA 01/2022 - 11/2020
2	pirfenidoneIBA 10/2021 - 01/2021
2	Competitive Endogenous RNAIBA 01/2021 - 11/2020
2	Cisplatin (Platino)FDA LinkGeneric 11/2020 - 11/2019
2	CytokinesIBA 06/2018 - 02/2011
2	OsteocalcinIBA 04/2018 - 02/2015
2	Indicators and Reagents (Reagents)IBA 04/2018 - 09/2013
2	Methylprednisolone FDA LinkGeneric 01/2015 - 01/2014
2	Monoamine Oxidase (MAO)IBA 02/2013 - 01/2012
2	RANK LigandIBA 07/2009 - 10/2005
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 12/2004 - 02/2000
1	Captopril (Capoten)FDA LinkGeneric 04/2022
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 04/2022
1	Drug CarriersIBA 03/2022
1	PolymersIBA 03/2022
1	MelatoninIBA 01/2022
1	Tranexamic Acid (AMCA)FDA Link 01/2021
1	CollagenIBA 01/2021
1	Circular RNAIBA 01/2021
1	Bone SubstitutesIBA 02/2020
1	Proline (L-Proline)FDA Link 01/2020
1	Annexin A5IBA 09/2019
1	chamaejasmineIBA 01/2019
1	cryptotanshinoneIBA 12/2018

Therapy/Procedure

11	Hip Replacement Arthroplasty (Total Hip Replacement) 12/2018 - 04/2006
6	Therapeutics 01/2019 - 04/2010
3	Decompression 03/2022 - 08/2012
3	Orthopedic Procedures 05/2021 - 05/2013
3	Knee Replacement Arthroplasty (Total Knee Replacement) 03/2021 - 10/2018
3	Prostheses and Implants (Prosthesis) 03/2021 - 04/2006
3	Transplantation 12/2015 - 11/2005
2	Precision Medicine 11/2020 - 01/2020
2	Arthroplasty 07/2020 - 02/2013
2	Osteotomy 01/2018 - 05/2013
2	Fracture Fixation 01/2017 - 07/2015
2	Intraperitoneal Injections 01/2017 - 01/2014
1	Injections 03/2022
1	Ovariectomy (Oophorectomy) 01/2022
1	Catheters 05/2021
1	Intra-Articular Injections 01/2021
1	Intravenous Administration 01/2021
1	Anterior Cruciate Ligament Reconstruction 01/2021
1	Sutures (Suture) 09/2020
1	Perioperative Period 06/2019
1	X-Ray Film 12/2018
1	Anesthesia 12/2018